HC Wainwright Forecasts Aemetis’ Q3 Earnings (NASDAQ:AMTX)

Aemetis, Inc (NASDAQ:AMTX) – Stock analysts at HC Wainwright boosted their Q3 2026 earnings per share estimates for shares of Aemetis in a research note issued to investors on Tuesday, August 18th. HC Wainwright analyst A. Dayal now forecasts that the specialty chemicals company will post earnings per share of ($0.19) for the quarter, up from their prior forecast of ($0.33). The consensus estimate for Aemetis’ current full-year earnings is ($1.12) per share. HC Wainwright also issued estimates for Aemetis’ Q4 2026 earnings at ($0.24) EPS, FY2026 earnings at ($0.88) EPS, FY2027 earnings at ($0.41) EPS, FY2028 earnings at $0.38 EPS, FY2029 earnings at $1.84 EPS and FY2030 earnings at $3.10 EPS.

Several other equities research analysts have also recently weighed in on the stock. Ascendiant Capital Markets upped their price objective on shares of Aemetis from $21.00 to $22.00 and gave the stock a “buy” rating in a research report on Friday, May 22nd. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aemetis in a report on Friday, July 17th. Finally, Wall Street Zen lowered shares of Aemetis from a “hold” rating to a “sell” rating in a research report on Saturday, June 6th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, Aemetis currently has a consensus rating of “Hold” and an average target price of $11.88.

Aemetis Stock Performance

Shares of NASDAQ AMTX opened at $1.86 on Thursday. The stock has a market capitalization of $134.24 million, a P/E ratio of -2.04 and a beta of 1.48. The stock’s fifty day moving average is $1.70 and its 200 day moving average is $2.07. Aemetis has a 52 week low of $1.30 and a 52 week high of $3.80.

Aemetis (NASDAQ:AMTX) last released its earnings results on Thursday, August 6th. The specialty chemicals company reported ($0.13) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.16. The company had revenue of $62.70 million for the quarter, compared to the consensus estimate of $67.69 million.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Bank of New York Mellon Corp acquired a new stake in shares of Aemetis during the second quarter worth $283,000. Bank of America Corp DE grew its holdings in Aemetis by 148.3% during the 1st quarter. Bank of America Corp DE now owns 101,486 shares of the specialty chemicals company’s stock worth $324,000 after acquiring an additional 60,611 shares during the period. Royal Bank of Canada raised its position in shares of Aemetis by 10,632.5% in the 1st quarter. Royal Bank of Canada now owns 8,908 shares of the specialty chemicals company’s stock worth $28,000 after acquiring an additional 8,825 shares in the last quarter. Renaissance Technologies LLC bought a new position in shares of Aemetis in the 1st quarter worth about $272,000. Finally, Sanctuary Advisors LLC acquired a new position in shares of Aemetis in the 1st quarter valued at about $33,000. 27.02% of the stock is owned by institutional investors and hedge funds.

Aemetis Company Profile

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.